Category: Clinical Trial Update Region: Asia · Korea, Republic of Company: Eubiologics Co Ltd

EuBiologics Phase III Clinical Trial IND Approval of EuCorVac-19, COVID-19 Vaccine Candidate in South Korea

By, Admin 1 min read
Share
EuBiologics Phase III Clinical Trial IND Approval of EuCorVac-19, COVID-19 Vaccine Candidate in South Korea
The first Phase III Clinical Trial IND Approval with Eubiologics

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!